Bionano Genomics Analyst Ratings
Scotiabank Maintains Bionano Genomics(BNGO.US) With Hold Rating, Maintains Target Price $1
Scotiabank Sticks to Their Hold Rating for BioNano Genomics (BNGO)
Ladenburg Thalmann Downgrades Bionano Genomics(BNGO.US) to Hold Rating
Bionano Genomics Analyst Ratings
BTIG Downgrades Bionano Genomics(BNGO.US) to Hold Rating
BTIG Downgrades BioNano Genomics (BNGO) to a Hold
Bionano Genomics Analyst Ratings
Scotiabank Downgrades Bionano Genomics(BNGO.US) to Hold Rating, Cuts Target Price to $1
BTIG Maintains Bionano Genomics(BNGO.US) With Buy Rating, Maintains Target Price $2
Buy Rating Affirmed for BioNano Genomics Amidst Operational Progress and Strategic Financial Planning
Maxim Group Reaffirms Their Hold Rating on BioNano Genomics (BNGO)
BTIG: Maintaining the Bionano Genomics (BNGO.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $3.00 to $2.00.
BTIG Maintains Buy on Bionano Genomics, Lowers Price Target to $2
Bionano Genomics Analyst Ratings
Strong Performance and Strategic Initiatives Underpin Buy Rating for BioNano Genomics
BioNano Genomics (BNGO) Gets a Buy From Scotiabank
BioNano Genomics (BNGO) Gets a Hold From Maxim Group
Bionano Genomics Analyst Ratings
A New Cause for Concern: Bionano Genomics Adds a New Share Price & Shareholder Rights Risk